Dr. Peter Tapley
Peter is a highly experienced research scientist with expertise in management of facilities under Good Laboratory Practice quality standards. He has acted as study director on numerous GLP compliant toxicology studies and a wide range of pharmacology models. His achievements in the areas of toxicology and oncology are recognised by memberships of the US Society of Toxicology and the American Association for Cancer Research.
He has a comprehensive understanding of industry drug development and regulatory processes. This knowledge is based on 20+ years of experience in the biotechnology and pharmaceutical industry in the United States and Australia. His experience includes scientist and management positions at Ligand Pharmaceuticals (San Diego), GlaxoSmithKline (Philadelphia), GroPep Ltd (Adelaide) and RDDT Laboratories/vivoPharm (Melbourne).
Dr. Hao Wang
Head, Bioanalytical Services
Hao obtained his Ph.D. in Environmental Chemistry in 2007 from New Jersey Institute of Technology and Rutgers, the State University of New Jersey. After graduation, Hao worked in leading bioanalytical CROs in east coast of New Jersey and Pennsylvania, including inventive Health Clinical, XenoBiotice Laborotories and Alliance Pharma, before moving to TetraQ in Australia.
With over 10 years working in Bioanalytical industry, Hao has extensive knowledge and hands-on experience in bioanalytical method development, validation and sample analysis for both small molecules (LC-MS/MS method) and big molecules (Ligand binding method). He is also familiar with US FDA and EMA regulations related to bioanalysis.
As a senior management member at TetraQ, Hao’s responsibilities include providing technical support to method development, resource planning for projects, reviewing and approving study protocols and reports, supervising study directors and evaluating and implementing new technologies/procedures. He ensures all studies are to client’s satisfaction, run to timelines and comply with regulatory requirement.
Mr. Simon Lake
Quality Assurance Manager
With a BSc (Hons) in Chemistry & MSc in Forensic Science, Simon Lake began his professional career with Glaxo Wellcome (now Glaxo SmithKline) where he worked as an Analytical Chemist in the UK. Having moved to Australia in 2006, Simon joined TetraQ as an Analyst & QA Representative for CIPDD/TetraQ ADME Bioanalytics before assuming the role of full-time Quality Assurance Manager for CIPDD/TetraQ in 2008.
Dr. Kanthi Lewis
Head, Commercial Operations